Provided by Tiger Trade Technology Pte. Ltd.

Madrigal Pharmaceuticals

523.26
-16.8000-3.11%
Post-market: 523.260.00000.00%19:30 EDT
Volume:259.41K
Turnover:135.02M
Market Cap:12.06B
PE:-36.81
High:539.71
Open:539.25
Low:513.36
Close:540.06
52wk High:615.00
52wk Low:393.61
Shares:23.06M
Float Shares:13.73M
Volume Ratio:1.23
T/O Rate:1.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.2164
EPS(LYR):-12.8501
ROE:-53.31%
ROA:-17.84%
PB:23.04
PE(LYR):-40.72

Loading ...

Nov 13, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 06, 2023

Major Issues Report

Form 8-K - Current report
Nov 06, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 06, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Oct 02, 2023

Major Issues Report

Form 8-K - Current report
Sep 25, 2023

Major Issues Report

Form 8-K - Current report
Sep 14, 2023

Major Issues Report

Form 8-K - Current report
Sep 14, 2023

Major Issues Report

Form 8-K - Current report
Sep 13, 2023

Major Issues Report

Form 8-K - Current report
Sep 11, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 09, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 17, 2023

Major Issues Report

Form 8-K - Current report
Jul 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 30, 2023

Major Issues Report

Form 8-K - Current report
Jun 26, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 26, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 20, 2023

Major Issues Report

Form 8-K - Current report
Jun 20, 2023

Major Issues Report

Form 8-K - Current report